Fehling Kara B, Selby Edward A
NYCBT, New York, NY, United States.
Department of Psychology, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.
Front Psychiatry. 2021 Feb 4;11:499980. doi: 10.3389/fpsyt.2020.499980. eCollection 2020.
Suicide continues to be one of the greatest challenges faced by mental health clinicians and researchers, an issue made worse by increasing trends in the global suicide rate. Suicide behavior disorder (SBD) was introduced in as a disorder for further consideration and potential acceptance into the diagnostic system. There are numerous positive developments that would arise from the addition of a suicide-related diagnosis. Utilizing the 2009 guidelines established by Kendler and colleagues, the present review examines the evidence for SBD's validity and discusses the diagnosis' potential clinical benefits and limitations. Altogether, growing evidence indicates that SBD has preliminary validity and benefit. SBD presents with several significant limitations, however, and possible alternative additions to future are highlighted.
自杀仍然是心理健康临床医生和研究人员面临的最大挑战之一,全球自杀率上升使这一问题更加严重。自杀行为障碍(SBD)于[具体年份]被提出,作为一种有待进一步考量并可能被纳入诊断系统的疾病。增加与自杀相关的诊断将会带来许多积极进展。本综述依据肯德勒及其同事于2009年制定的指南,审视了支持SBD有效性的证据,并探讨了该诊断潜在的临床益处及局限性。总体而言,越来越多的证据表明SBD具有初步的有效性和益处。然而,SBD也存在一些重大局限性,文中还强调了未来[具体版本]可能的替代补充内容。